Emil Kakkis

Emil Kakkis Email and Phone Number

United States
Emil Kakkis's Location
United States, United States
Emil Kakkis's Contact Details

Emil Kakkis personal email

n/a
About Emil Kakkis

I have spent my career so far seeking to develop new treatments for rare diseases that built upon my training in biochemistry, medicine and research. I have had the good fortune to succeed in developing and getting FDA approval for 3 medicines for rare disease patients, and getting another 3 into clinical studies. My goals going forward are to work on improving the regulatory process that controls how rare disease treatments get developed. I have gone back to biotech again in 2010, starting Ultragenyx Pharmaceutical Inc. We now will have 4 products in 5 clinical programs this year and team of about 70 people. We have gone public in an IPO in January 2014. The development team are working to treat some of the many untreated rare diseases and focused on translating these therapies as promptly as possible. It can never be fast enough. Specialties: Drug development in rare diseasesBiochemical genetic disease treatmentMucopolysaccharidoses and their clinical management

Emil Kakkis's Current Company Details
Bay Area Creative Foundation

Bay Area Creative Foundation

View
Founder
United States
Employees:
5
Emil Kakkis Work Experience Details
  • Bay Area Creative Foundation
    Founder
    Bay Area Creative Foundation
    United States
  • Actio Biosciences, Inc.
    Board Member
    Actio Biosciences, Inc. Jul 2024 - Present
    San Diego, Ca, Us
  • Actio Biosciences, Inc.
    Board Member
    Actio Biosciences, Inc. Jul 2024 - Jul 2024
    San Diego, Ca, Us
  • Ultragenyx Pharmaceutical Inc.
    Founder, Chief Executive Officer And President
    Ultragenyx Pharmaceutical Inc. Apr 2010 - Present
    Novato, California, Us
    Ultragenyx is a biotechnology company focused on development of drugs for rare and ultrarare genetic disorders. Formed in April 2010, The company went public on January 31, 2014 on NASDAQ with the symbol RARE. The company has 4 approved products for the treatment of five indications MPS 7, XLH, TIO, LC-FAOD and familial hypercholesterolemia diseases. The company has advanced stage programs in gene therapy for multiple diseases and programs in OI and Angelman syndrome. The company is headquartered in Novato, California, USA and has commercial presence in the US, Canada, EU, Turkey, MENA, Latin America and Japan. Go to www.ultragenyx.com for more information.
  • Everylife Foundation For Rare Diseases
    Board Member
    Everylife Foundation For Rare Diseases May 2009 - May 2023
    Washington, District Of Columbia, Us
  • Everylife Foundation For Rare Diseases
    President
    Everylife Foundation For Rare Diseases Mar 2009 - Sep 2016
    Washington, District Of Columbia, Us
    The EFRD was formed to improve the development process for very rare disorders. The use of biomarkers as primary endpoints and improved design of clinical studies for rare disorders are two initiatives that are part of the general goal of "accelerating treatment for rare disorders". The EFRD succeeded in getting legislation into FDASIA that could improve access to the accelerated approval pathway. Go to www.everylifefoundation.org for more information and sign up for updates.
  • National Organization For Rare Disorders
    Board Member
    National Organization For Rare Disorders 2009 - Nov 2011
  • Biomarin
    Development Consultant
    Biomarin Mar 2009 - Jun 2010
    San Rafael, Ca, Us
    After 10 years, I have moved on from BioMarin but am still a development consultant for them during the coming year. I have started a Foundation now to accelerate the development of treatments for rare diseases. Go to www.curetheprocess.org
  • Biomarin
    Chief Medical Officer
    Biomarin Sep 1998 - Feb 2009
    San Rafael, Ca, Us
  • Harbor-Ucla Research And Education Institute
    Assistant Professor
    Harbor-Ucla Research And Education Institute 1993 - 1998
  • Harbor Ucla Med Center, Research And Education Institute
    Assistant Professor
    Harbor Ucla Med Center, Research And Education Institute 1993 - 1998

Emil Kakkis Skills

Biotechnology Drug Development Clinical Trials Genetics Clinical Research Biochemistry Fda Life Sciences Pharmaceutical Industry Clinical Development Start Ups Oncology Medicine Drug Discovery Lifesciences Regulatory Submissions Commercialization Biomarkers Infectious Diseases

Emil Kakkis Education Details

  • Ucla
    Ucla
    Biological Chemistry
  • Pomona College
    Pomona College
    Biology
  • Wilson High School Of Long Beach Ca
    Wilson High School Of Long Beach Ca

Frequently Asked Questions about Emil Kakkis

What company does Emil Kakkis work for?

Emil Kakkis works for Bay Area Creative Foundation

What is Emil Kakkis's role at the current company?

Emil Kakkis's current role is Founder.

What is Emil Kakkis's email address?

Emil Kakkis's email address is ek****@****mrn.com

What schools did Emil Kakkis attend?

Emil Kakkis attended Ucla, Pomona College, Wilson High School Of Long Beach Ca.

What are some of Emil Kakkis's interests?

Emil Kakkis has interest in Exercise, Home Improvement, Reading, Shooting, Gourmet Cooking, Sports, Food, Home Decoration, Health, Diy.

What skills is Emil Kakkis known for?

Emil Kakkis has skills like Biotechnology, Drug Development, Clinical Trials, Genetics, Clinical Research, Biochemistry, Fda, Life Sciences, Pharmaceutical Industry, Clinical Development, Start Ups, Oncology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.